1/03/2012

15 Healthcare Dividend Stocks With Buy Or Better Recommendation

Healthcare Dividend Shares With Buy And Stong Buy Rating researched by Dividend Yield - Stock, Capital, Investment. Here is a current overview of stocks from the healthcare sector with a minimum dividend yield of 3 percent that have an actual buy or better rating outstanding. The recommendations are made by analysts and brokerage firms and measured on a scale between one and five. I listed all healthcare dividend stocks with a rating above 3 (buy or better). Exactly 15 companies fulfilled these criteria of which 8 have a strong buy rating and 7 a buy recommendation.

Here are the 3 top dividend stocks sorted by yield:
(Subscribe my Blog via RSS Feed or E-Mail. Alternative, you can follow me on Facebook or Twitter)


Psychemedics (NASDAQ: PMD) has a market capitalization of $47.64 million. The company employs 91 people, generates revenues of $20.11 million and has a net income of $2.61 million. The firm’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $4.70 million. Because of these figures, the EBITDA margin is 23.36 percent (operating margin 21.95 percent and the net profit margin finally 13.00 percent).


The total debt representing 0.00 percent of the company’s assets and the total debt in relation to the equity amounts to 0.00 percent. Due to the financial situation, a return on equity of 27.45 percent was realized. Twelve trailing months earnings per share reached a value of $0.66. Last fiscal year, the company paid $0.48 in form of dividends to shareholders.


Here are the price ratios of the company: The P/E ratio is 13.76, Price/Sales 2.37 and Price/Book ratio 4.87. Dividend Yield: 5.27 percent. The beta ratio is 0.84.


Long-Term Stock History Chart Of Psychemedics Corp. (Click to enlarge)


Long-Term History of Dividends from Psychemedics Corp. (NASDAQ: PMD) (Click to enlarge)


Long-Term Dividend Yield History of Psychemedics Corp. (NASDAQ: PMD) (Click to enlarge)


GlaxoSmithKline (NYSE: GSK) has a market capitalization of $115.53 billion. The company employs 96,461 people, generates revenues of $44,106.82 million and has a net income of $2,878.62 million. The firm’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $8,494.51 million. Because of these figures, the EBITDA margin is 19.26 percent (operating margin 13.32 percent and the net profit margin finally 6.53 percent).


The total debt representing 35.76 percent of the company’s assets and the total debt in relation to the equity amounts to 169.91 percent. Due to the financial situation, a return on equity of 17.30 percent was realized. Twelve trailing months earnings per share reached a value of $2.02. Last fiscal year, the company paid $2.02 in form of dividends to shareholders.


Here are the price ratios of the company: The P/E ratio is 22.61, Price/Sales 2.60 and Price/Book ratio 8.41. Dividend Yield: 4.83 percent. The beta ratio is 0.63.


Long-Term Stock History Chart Of GlaxoSmithKline plc (ADR) (Click to enlarge)


Long-Term History of Dividends from GlaxoSmithKline plc (ADR) (NYSE: GSK) (Click to enlarge)


Long-Term Dividend Yield History of GlaxoSmithKline plc (ADR) (NYSE: GSK) (Click to enlarge)


Sanofi SA (NYSE: SNY) has a market capitalization of $98.09 billion. The company employs 101,575 people, generates revenues of $41,469.25 million and has a net income of $5,640.13 million. The firm’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $13,867.96 million. Because of these figures, the EBITDA margin is 33.44 percent (operating margin 18.59 percent and the net profit margin finally 13.60 percent).


The total debt representing 9.69 percent of the company’s assets and the total debt in relation to the equity amounts to 15.56 percent. Due to the financial situation, a return on equity of 10.78 percent was realized. Twelve trailing months earnings per share reached a value of $2.29. Last fiscal year, the company paid $1.62 in form of dividends to shareholders.


Here are the price ratios of the company: The P/E ratio is 15.93, Price/Sales 2.38 and Price/Book ratio 1.39. Dividend Yield: 4.83 percent. The beta ratio is 0.89.


Long-Term Stock History Chart Of Sanofi SA (ADR) (Click to enlarge)


Long-Term History of Dividends from Sanofi SA (ADR) (NYSE: SNY) (Click to enlarge)


Long-Term Dividend Yield History of Sanofi SA (ADR) (NYSE: SNY) (Click to enlarge)

Here is the full table with some fundamentals (TTM):

15 Healthcare Dividend Stocks With Buy Or Better Recommendation (Click to enlarge)

Take a closer look at the full table. The average price to earnings ratio (P/E ratio) amounts to 17.45 while the forward price to earnings ratio is 12.11. The dividend yield has a value of 3.99 percent. Price to book ratio is 3.11 and price to sales ratio 2.28. The operating margin amounts to 18.50 percent.

Related stock ticker symbols:
PMD, SNY, GSK, NDZ, MRK, NVS, PFE, VIVO, AVCA, BMY, UTMD, JNJ, ABT, MSA, LNCR

Selected Articles:

I am long JNJ. I receive no compensation to write about these specific stocks, sector or theme. I don't plan to increase or decrease positions or obligations within the next 72 hours.

For the other stocks: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I receive no compensation to write about any specific stock, sector or theme.

No comments:

Post a Comment

Do you have any questions or notes to this article?
Please let me know your thoughts and we will discuss it.

If you feel that my work has helped you and you'd like to support my mission to spread investment ideas like honesty, openness, unconditional love, and courage, please make a donation below. I'm very grateful for your support.

Being supported by my readers enables me to give my creative output (articles, pdf free downloads) to the public domain, so it isn't copyrighted. Please share it freely so that others may benefit from it.

Thanks so much for your support. I really appreciate it.

To donate via PayPal, credit card, or e-check, please click the button below:

If you like to receive the Dividend Weekly for free (weekly published E-Book with around 1,000 best dividend paying stocks), please enter your email and verify your adress. Easily unsubscribe at any time.